Design and execute the proposed experiment to test the hypothesis: 'TYROBP (DAP12) Conditional Antagonism for Early-Stage Neuroprotection'. Primary outcome: >=40% TYROBP knockdown in microglia; >=20% preservation of synaptic puncta at 6 months vs 5xFAD-vehicle. Estimated cost: $95,000; timeline: 20 months.